Progress to activity-specific movements at reduced intensity
This compounded preparation is not approved by the FDA
Risks and considerations "Compared with placebo and active comparator, semaglutide induces mostly mild and transient gastrointestinal disturbances and increases the risk of cholelithiasis." 16 It does not alter the levels of commonly used medications like HRT, metformin, or diuretics
Legal status complicates everything
For semaglutide, these types of tests are not routinely available yet
Ogino K, Izumi Y, Segawa H, Takeyama Y, Ishiyama H, Houbara T, et al